Safety of tranexamic acid in pediatric cardiac surgery: what we do not know

被引：6
作者：
Faraoni, David [1 ]
机构：
[1] CHU Brugmann HUDE RF, Dept Anesthesiol, B-1020 Brussels, Belgium
来源：
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY | 2011年 / 40卷 / 06期
关键词：
Tranexamic acid; Antifibrinolytic therapy; Transfusion; Pediatric cardiac surgery; Congenital heart disease; Seizures; APROTININ;
D O I：
10.1016/j.ejcts.2011.03.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1550 / 1551
页数：4
相关论文
共 3 条
  • [1] The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery
    Breuer, Tamas
    Martin, Klaus
    Wilhelm, Markus
    Wiesner, Gunther
    Schreiber, Christian
    Hess, John
    Lange, Ruediger
    Tassani, Peter
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2009, 35 (01) : 167 - 171
  • [2] Tranexamic acid versus ε-aminocaproic acid: efficacy and safety in paediatric cardiac surgery
    Martin, Klaus
    Breuer, Tamas
    Gertler, Ralph
    Hapfelmeier, Alexander
    Schreiber, Christian
    Lange, Ruediger
    Hess, John
    Wiesner, Gunther
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2011, 39 (06) : 892 - 897
  • [3] The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: A meta-analysis
    Schouten, Esther S.
    van de Pol, Alma C.
    Schouten, Anton N. J.
    Turner, Nigel M.
    Jansen, Nicolaas J. G.
    Bollen, Casper W.
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2009, 10 (02) : 182 - 190
1